KINLEIGH LIMITED

Company number 00913323 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Score: A-

Explanation: Kinleigh Limited is in excellent financial health, demonstrating a strong recovery and robust vitality in its recent financial period. The company has significantly improved its profitability and revenue, indicating a resilient business model. However, a notable drop in cash reserves and a recent major change in ownership and leadership (the "Lomond acquisition") introduce mild transitional risks, preventing a perfect score. The patient is fundamentally healthy but undergoing a significant regime change that requires careful monitoring.


1. Key Vital Signs

  • Revenue (The Heartbeat): £89.5 million Up from £74 million in the prior year. This represents a strong, steady pulse, indicating robust market demand and operational effectiveness. The 13-month period naturally inflates this slightly, but the underlying growth is undeniably healthy.
  • Profit Before Tax (Immune Strength): £7.32 million A massive improvement from £0.75 million in 2023. The business has successfully fought off previous margin pressures, translating its revenue directly into bottom-line strength.
  • Net Assets (Bone Density): £23.88 million Up from £21.66 million. The structural foundation of the business is solid, with assets well exceeding liabilities, ensuring the company is standing on firm ground.
  • Cash Reserves (Hydration Levels): £5.63 million Down significantly from £14.08 million. This is a symptom that requires attention. While profitable on paper, the business has experienced a severe drop in liquid reserves, possibly due to the acquisition, dividend payouts, or working capital shifts.
  • Total Liabilities (Cholesterol): £8.2 million Up slightly from £6.8 million. Well-managed and easily covered by the asset base, meaning the company is not over-leveraged.

2. Diagnosis

The Patient is Fit, but Experiencing Post-Acquisition Transition Symptoms

The financial data reveals a business that has found its stride operationally. The 21% increase in revenue and the nearly tenfold increase in pre-tax profit indicate that the strategic and structural changes implemented in 2023 acted as an effective course of treatment for previous margin weaknesses. The adjusted EBITDA of £9.37 million shows strong operational cash generation capability.

However, there are two significant "symptoms" to monitor:

  1. Acute Cash Dehydration: Despite strong profitability, cash reserves dropped by over £8.4 million. This is a classic presentation when a company is undergoing M&A activity or restructuring. The payment of a £1.5 million interim dividend and potential acquisition-related costs likely drained these reserves. While not immediately fatal given the strong profit generation, low cash limits emergency flexibility.
  2. Corporate DNA Transfusion: On January 31, 2025, Lomond Property Lettings Limited took controlling interest (>75% shares), resulting in a near-complete replacement of the Board of Directors. This represents a major "surgical procedure" to the corporate governance structure. While the strategic intent is positive (focusing on non-cyclical revenues and CRM investment), such rapid leadership turnover inherently carries integration risks.

3. Recommendations

To maintain peak financial wellness and ensure a smooth recovery from the recent acquisition, the following preventative and proactive measures are recommended:

  • Rehydrate Cash Reserves: Prioritize rebuilding the cash buffer in the next 12-24 months. While the £5.6m remaining is adequate for current operations, a business of this scale ideally needs higher liquid reserves to weather unexpected market downturns or seasonal fluctuations.
  • Post-Operative Integration Care: The new Lomond-backed board must focus on cultural and operational integration. With almost the entire board turning over, there is a risk of strategic whiplash. Clear communication and retention of key long-serving staff (noted as an asset in the strategic report) will be critical.
  • Focus on Preventative Revenue Streams: The strategic report correctly identifies a need to focus on non-cyclical revenues (like Residential Lettings). The UK residential sales market is highly sensitive to interest rates; diversifying revenue acts as a preventative vaccine against future market "pandemics."
  • Monitor Working Capital: Investigate the root cause of the cash drop beyond the known dividend and acquisition costs. Ensure that debtor days are not extending and that the business is collecting its receivables efficiently to prevent future cash flow blockages.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 30 July 2026